Announced
Completed
AMBRX INC. / WUXI PHARMATECH (CAYMAN) INC. / SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO. LTD. / HOPU INVESTMENT MANAGEMENT COMANY LTD. / CHINA EVERBRIGHT LIMITED / VERSANT VENTURES / ROCHE VENTURE FUND / CMEA VENTURES / ARAVIS VENTURES / APPOSITE CAPITAL LLP / 5AM VENTURES LLC / Public / Acquisition
Synopsis
Sale of Ambrx, a biopharmaceutical company engaged in the discovery, development, and commercialization of protein-based drugs, to a consortium of Chinese companies.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite